Fig. 3.

Prognosis of liver cirrhosis benefited from statin treatment in long term

follow-up. a mortality; b decompensation events (8 studies - Bang et al., [23]; Chang et al., [25]; Kaplan et al., [28]; Kumar et al., [30]; Mohanty et al., [31]; Abraldes et al., [22]; Bishnu et al., [24]; and Wong et al., [36]); c esophageal variceal bleeding (5 studies); d spontaneous bacterial peritonitis (SBP) (4 studies); e hepatic encephalopathy (HE) (3 studies); f ascites (4 studies); g HCC (hepatocellular carcinoma) development (4 studies); h liver transplantation rate (2 studies)